Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001638599-18-001126)

Filing Details

Accession Number:: 0001638599-18-001126
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-09-26 17:21:23
Reporting Period:: 2018-09-24

Accepted Time:: 2018-09-26 17:21:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1682639	Eyenovia Inc.	EYEN	Pharmaceutical Preparations (2834)	471178401

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1744774	M Michael Rowe	C/O Eyenovia, Inc. 501 Fifth Avenue, Suite 1404 New York NY 10017	Vice President Of Marketing	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $.0001	Acquisiton	2018-09-24	200	$4.09	400	No	4	P	Direct
Common Stock, Par Value $.0001	Acquisiton	2018-09-25	600	$4.27	1,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (right to buy)	$6.30		2028-07-02	60,000	60,000	Direct
Common Stock	Stock Option (right to buy)	$6.20		2028-07-24	19,874	19,874	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2028-07-02	60,000	60,000	Direct
2028-07-24	19,874	19,874	Direct

Footnotes

The option became exercisable as to 1,666 shares on August 2, 2018, and becomes exercisable in equal 1,666 share amounts on each of the 35 one-month anniversaries thereafter.
One-third of the option becomes exercisable on July 24, 2019 and the remaining shares underlying the option become exercisable in equal increments on each of the 24-one month anniversaries thereafter.